Dermatology
3 drugs are in development for Systemic Sclerosis.
- Companies
- 3
- Clinical trials
- 19
BioSniper AIPage evidence connected
Prepared research question
Which programs lead the Systemic Sclerosis pipeline—and what evidence could change the picture?
Run cited research
Traceable citations · Unknowns marked
Drug Pipeline by Phase
Phase 1/Phase 2(1)
| Drug | Company |
|---|---|
| nkx019 | Nkarta, Inc. (NKTX) |
Phase 2/Phase 3(2)
About this indication
Systemic Sclerosis context
Dermatology·MeSH: Scleroderma, Systemic (D012595)
Also known as: Systemic Scleroderma
Compare drugs
Frequently asked questions
How many drugs are in development for Systemic Sclerosis?
BioSniper tracks 3 drugs in development for Systemic Sclerosis across 3 companies.
How many clinical trials target Systemic Sclerosis?
There are 19 clinical trials targeting Systemic Sclerosis tracked by BioSniper.